International study to evaluate efficacy and safety in treating a leading cause of blindness
- Details
- Category: Bayer

Highlight Potential of Novel Oral Compound for Gaucher Disease
- Details
- Category: Genzyme

Bayer Schering Pharma to market new low-dose oral contraceptive YAZ® in Europe
- Details
- Category: Bayer

European Commission grants full approval of HIV protease inhibitor, tipranavir (Aptivus®)
- Details
- Category: Boehringer Ingelheim

Novo Nordisk researchers nominated for Europe's top innovation prize
- Details
- Category: Novo Nordisk

GlaxoSmithKline commences tender offer to acquire Sirtris Pharmaceuticals
- Details
- Category: GlaxoSmithKline

Abbott, Takeda Conclude TAP Joint Venture
- Details
- Category: Abbott

More Pharma News ...
- Esperion Therapeutics Completes $22.75 M Series A Financing
- Lundbeck expands geographical rights for Circadin®
- AstraZeneca Submits sNDA for SYMBICORT® for COPD Treatment
- Novo Nordisk will donate a licence to its small molecule compound library
- Follicular lymphoma: EU approval for Zevalin® as First-Line Consolidation Treatment
- Amgen's First Quarter 2008 Adjusted Earnings Per Share Increased 4 percent to $1.12
- Pfizer Enters into Research Consortium to Expand Understanding of Diabetes and Obesity Pathobiology